GHRP-6 vs Hexarelin
Updated November 4, 2026 · Reviewed by the PeptidesDB Editorial team
A data-driven comparison of GHRP-6 and Hexarelin (also searched as Hexarelin vs GHRP-6) — effect profiles, evidence, side effects, and which suits weight loss, muscle, or healing goals.
Verdict
GHRP-6 centers on muscle, while Hexarelin leans toward muscle. On indexed research, GHRP-6 is ahead (GHRP-6: 18 studies, Human clinical; Hexarelin: 7, Human evidence). Choose by goal — and read the primary studies. This is research information, not medical advice.
Key takeaways
- •GHRP-6 is strongest for muscle; Hexarelin for muscle.
- •Evidence: GHRP-6 Human clinical (18 studies) vs Hexarelin Human evidence (7).
- •Both are research-use compounds — not FDA-approved.
Effect profiles, overlaid
At a glance
GHRP-6 vs Hexarelin: side-by-side
| Metric | GHRP-6 | Hexarelin |
|---|---|---|
| Class | Muscle | Muscle |
| Regulatory status | Research use only | Research use only |
| Evidence grade | Human clinical | Human evidence |
| Studies indexed | 18 | 7 |
| Research level | Moderate Research | Preclinical |
| Strongest effect | Muscle & body comp | Muscle & body comp |
| Healing & recovery | 3.0▲ | 2.0 |
| Muscle & body comp | 4.0▲ | 4.0▲ |
| Metabolic & appetite | 3.0▲ | 3.0▲ |
| Neuro & mood | 2.0 | 3.0▲ |
| Sleep & circadian | 2.0▲ | 1.0 |
| Inflammation & immune | 3.0▲ | 2.0 |
| Skin & aesthetics | 2.0▲ | 1.0 |
▲ marks the higher AI-assigned effect score (0–5, describing where the literature concentrates — not clinical efficacy).
Mechanism & pharmacokinetics
| Property | GHRP-6 | Hexarelin |
|---|---|---|
| Mechanism | Ghrelin receptor agonist | GHS-R agonist |
| Route | Subcutaneous injection | Subcutaneous injection |
| Half-life | — | ~2.5 hours |
| Time to peak | — | 30 min |
| Duration of action | — | ~6 hours |
Established pharmacology — curated for well-characterized compounds and AI-summarized otherwise. A blank (—) means no reliable single value is published (half-life figures for some peptides genuinely disagree across sources). Verify against primary sources such as FDA labels and ClinicalTrials.gov.
What is GHRP-6?
GHRP-6 (Growth Hormone Releasing Peptide-6) is a synthetic hexapeptide that acts as a growth hormone secretagogue (GHS). It primarily stimulates the release of growth hormone (GH) from the anterior pituitary gland through the activation of the ghrelin receptor (GHS-R). This mechanism is believed to be mediated by the stimulation of the hypothalamus, which subsequently promotes the release of growth hormone-releasing hormone (GHRH) and inhibits somatostatin, thereby enhancing GH secretion.
Full GHRP-6 profile, mechanism & studies →What is Hexarelin?
Hexarelin is a synthetic hexapeptide that belongs to the growth hormone secretagogue (GHS) class, known for its ability to stimulate growth hormone release from the pituitary gland. It has been investigated for its potential therapeutic applications in various conditions, including muscle wasting and age-related decline in growth hormone levels.
Full Hexarelin profile, mechanism & studies →Which is better for your goal?
| Goal | Better fit | Why |
|---|---|---|
| Healing | GHRP-6 | 3.0/5 effect signal |
| Muscle | Even | Both ~4.0/5 |
| Metabolic | Even | Both ~3.0/5 |
| Neuro | Hexarelin | 3.0/5 effect signal |
| Sleep | GHRP-6 | 2.0/5 effect signal |
| Inflammation | GHRP-6 | 3.0/5 effect signal |
| Skin | GHRP-6 | 2.0/5 effect signal |
Fit reflects community-perceived effect profiles — not head-to-head trials. Read each peptide's studies before deciding.
Can you stack GHRP-6 and Hexarelin?
People sometimes combine peptides that target different pathways, but there is little controlled research on this specific pairing and the interactions aren't well characterized. Because neither compound is FDA-approved, we don't publish stacking or dosing protocols here. Any combination should be discussed with a qualified clinician.
GHRP-6 vs Hexarelin: side effects
No community-reported effects logged yet.
No community-reported effects logged yet.
Anonymous community reports (count = number of reports), not clinical incidence rates.
What the research says
GHRP-6 has 18 approved studies indexed (Human clinical), and Hexarelin has 7 (Human evidence). The Librarian re-checks PubMed, Europe PMC and ClinicalTrials daily, so these counts move. Open each profile to read the summaries and sources.
Frequently asked questions
Is GHRP-6 or Hexarelin better?
It depends on your goal. GHRP-6 is strongest for muscle; Hexarelin for muscle. GHRP-6 has more indexed studies (18). See the goal-by-goal breakdown above.
Is GHRP-6 or Hexarelin better for weight loss?
They score similarly on the metabolic/appetite axis in the community data.
Is GHRP-6 or Hexarelin better for muscle?
Both land close on the muscle & body-composition axis.
Which has more research, GHRP-6 or Hexarelin?
GHRP-6 has 18 approved studies indexed (Human clinical); Hexarelin has 7 (Human evidence). Higher counts mean more to read, not proven superiority.
Can you stack GHRP-6 and Hexarelin?
Some users combine peptides, but there's little controlled data on this specific pairing, and interactions aren't well characterized. We don't publish stacking protocols for compounds that aren't FDA-approved. Discuss any combination with a qualified clinician.
What are the side effects of GHRP-6 vs Hexarelin?
GHRP-6: no community-reported effects logged yet. Hexarelin: none logged yet. These are anonymous reports, not incidence rates — see each profile.
Is GHRP-6 or Hexarelin FDA-approved?
GHRP-6 is a research-use compound and is not FDA-approved. Hexarelin is not FDA-approved. Research-use status is not a legal clearance to compound or use in humans.
Is Hexarelin better than GHRP-6?
For muscle, Hexarelin has the edge; for muscle, GHRP-6 does. Neither is universally "better" — it's goal-dependent, and both should be weighed against their evidence base above.
Comparing related peptides
Regulatory & legal status
GHRP-6 and Hexarelin are research-use compounds and are not FDA-approved for human use. FDA approval and compounding rules for peptides change frequently, and research-use status is not a legal clearance for human use. The FDA does not review compounded drugs for safety, effectiveness, or quality. Verify current status with primary sources before acting. Last reviewed November 4, 2026.